Ciancetta Antonella, Jacobson Kenneth A
Molecular Recognition Section (MRS), Laboratory of Bioorganic Chemistry, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MA 20892, USA.
Molecules. 2017 Mar 11;22(3):449. doi: 10.3390/molecules22030449.
Adenosine is an endogenous modulator exerting its functions through the activation of four adenosine receptor (AR) subtypes, termed A₁, A, A and A₃, which belong to the G protein-coupled receptor (GPCR) superfamily. The human A₃AR (hA₃AR) subtype is implicated in several cytoprotective functions. Therefore, hA₃AR modulators, and in particular agonists, are sought for their potential application as anti-inflammatory, anticancer, and cardioprotective agents. Structure-based molecular modeling techniques have been applied over the years to rationalize the structure-activity relationships (SARs) of newly emerged A₃AR ligands, guide the subsequent lead optimization, and interpret site-directed mutagenesis (SDM) data from a molecular perspective. In this review, we showcase selected modeling-based and guided strategies that were applied to elucidate the binding of agonists to the A₃AR and discuss the challenges associated with an accurate prediction of the receptor extracellular vestibule through homology modeling from the available X-ray templates.
腺苷是一种内源性调节剂,通过激活四种腺苷受体(AR)亚型发挥其功能,这四种亚型分别称为A₁、A₂、A₂和A₃,它们属于G蛋白偶联受体(GPCR)超家族。人类A₃AR(hA₃AR)亚型与多种细胞保护功能有关。因此,人们正在寻找hA₃AR调节剂,尤其是激动剂,以探索它们作为抗炎、抗癌和心脏保护剂的潜在应用。多年来,基于结构的分子建模技术已被用于合理化新出现的A₃AR配体的构效关系(SAR),指导后续的先导化合物优化,并从分子角度解释定点诱变(SDM)数据。在这篇综述中,我们展示了一些基于建模和导向的策略,这些策略被用于阐明激动剂与A₃AR的结合,并讨论了通过从可用的X射线模板进行同源建模来准确预测受体细胞外前庭所面临的挑战。